Associated Papers
Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry.
Bateman NW et al.
Iscience, 2022
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia.
Fontana D et al.
Hemasphere, 2020
Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease.
Cafiero C et al.
Pharmacogenomics and Personalized Medicine, 2020
The genetic landscape of the human solute carrier (SLC) transporter superfamily.
Schaller L et al.
Human Genetics, 2019
Sex-specific and pleiotropic effects underlying kidney function identified from GWAS meta-analysis.
Graham SE et al.
Nature Communications, 2019
Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy.
Limviphuvadh V et al.
Bmc Cancer, 2018
Characterization of Disease-Associated Mutations in Human Transmembrane Proteins.
Molnár J et al.
Plos One, 2016
Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment.
Boglione L et al.
Archives of Virology, 2015
Genetic factors affecting drug disposition in Asian cancer patients.
Syn NL et al.
Expert Opinion on Drug Metabolism & Toxicology, 2015
Development of a novel, fully-automated genotyping system: principle and applications.
Suzuki S et al.
Sensors (basel, Switzerland), 2012
Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment.
D'Avolio A et al.
Therapeutic Drug Monitoring, 2012
Effect of genetic polymorphisms of SLC28A1, ABCG2, and ABCC4 on bioavailability of mizoribine in healthy Japanese males.
Fukao M et al.
Drug Metabolism and Pharmacokinetics, 2011
Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.
Tanaka M et al.
Cancer, 2010
Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity.
Okazaki T et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2010
Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients.
Soo RA et al.
Lung Cancer (amsterdam, Netherlands), 2009
Identification and functional analysis of variants in the human concentrative nucleoside transporter 2, hCNT2 (SLC28A2) in Chinese, Malays and Indians.
Li L et al.
Pharmacogenetics and Genomics, 2007
Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2.
Owen RP et al.
Pharmacogenetics and Genomics, 2005
Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patients.
Wong AL et al.
Cancer Genomics & Proteomics, 0